广州医药 ›› 2020, Vol. 51 ›› Issue (2): 65-67.DOI: 10.3969/j.issn.1000-8535.2020.02.014

• 论著 • 上一篇    下一篇

纤维支气管镜下给药治疗耐多药空洞型肺结核疗效研究

翁加豪, 陈伟生, 杨仪, 杨贤明   

  1. 汕头市第三人民医院(汕头 515000)
  • 收稿日期:2019-11-14 出版日期:2020-03-20 发布日期:2021-11-28

Study on the therapeutic effect of multi drug resistant cavitary pulmonary tuberculosis treated by fiberoptic bronchoscopy

WENG Jiahao, CHEN Weisheng, YANG Yi, YANG Xianming   

  1. Shantou Third People's Hospital, Shantou 515000,China
  • Received:2019-11-14 Online:2020-03-20 Published:2021-11-28

摘要: 目的 研究纤维支气管镜下给药治疗耐多药空洞型肺结核的临床治疗效果。方法 抽取我院2017年1月—2019年12月期间收治的空洞型肺结核耐多药(同时耐INH、RFP,其他药敏试验抗痨药物均敏感)患者74例作为研究对象,其中38例设作治疗组,在应用传统抗痨药物帕司烟肼、EMB、PZA、TH1321治疗基础上,应用纤维支气管镜下给药治疗,药物选择AMK和左氧氟沙星;36例设作对照组,单纯应用传统抗结核药物帕司烟肼、EMB、PZA、TH1321治疗,比较两组临床治疗效果。结果 治疗组临床治疗总有效率94.7%,高于对照组66.7%,两组比较差异有统计学意义(P<0.05);治疗后,两组QOL评分均高于治疗前,治疗组评分高于对照组,比较差异有统计学意义(P<0.05);治疗组患者痰菌转阴时间、病灶减少时间、空洞缩小时间等指标均优于对照组,比较差异有统计学意义(P<0.05);两组不良反应比较无差异(P>0.05)。结论 纤维支气管镜下给药应用AMK和左氧氟沙星,可以有效治疗耐多药空洞型肺结核,取得理想的临床治疗效果,能有效改善患者临床症状,缩短痰菌转阴、病灶减少和空洞缩小的时间,有效改善患者的生活质量,而且治疗安全性较高,可以应用于临床推广。

关键词: 纤维支气管镜, 阿米卡星, 左氧氟沙星, 耐多药空洞型结核, 治疗效果

Abstract: Objective To study the clinical effect of drug administration under fiberoptic bronchoscope in the treatment of multi drug resistant (mdr) cavitary pulmonary tuberculosis. Methods 74 patients with cavitary pulmonary tuberculosis(who were resistant to INH and RFP at the same time and sensitive to other drugs in other drug sensitivity tests) were selected as the study subjects. 38 of them were set up as the treatment group. On the basis of the treatment with traditional antituberculosis drugs such as pasiazide, EMB, PZA and TH1321, they were treated with fiberoptic bronchoscopy and drug selection AMK and levofloxacin, 36 cases as control group, were treated with traditional antituberculotic drugs, such as pasiazide, EMB, PZA and TH1321. Results The total effective rate of clinical treatment in the treatment group was 94.7%, higher than 66.7% in the control group, and the difference between the two groups was statistically significant(P<0.05);there was no difference in adverse reactions between the two groups(P>0.05). Conclusion Administration of AMK and levofloxacin under fiberbronchoscope may effectively treat mdr-cavitary tuberculosis, achieve ideal clinical treatment effect, effectively improve the clinical symptoms of patients, shorten the time of sputum bacteria turning negative, focus reduction and cavitary reduction, effectively improve the quality of life of patients. The treatment safety is high, which may be applied in clinical promotion.

Key words: Fiberbronchoscope, Amikacin, Levofloxacin, Multidrug-resistant cavity tuberculosis, Therapeutic effect